Click to copy
Click to copy

Karyopharm Therapeutics: 2Q Earnings Snapshot

August 6, 2019

NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $43.4 million in its second quarter.

The Newton, Massachusetts-based company said it had a loss of 71 cents per share.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 97 cents per share.

The pharmaceutical company posted revenue of $9.5 million in the period.

Karyopharm Therapeutics shares have decreased 17% since the beginning of the year. The stock has fallen 56% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI

All contents © copyright 2019 The Associated Press. All rights reserved.